Molecular and clinicopathologic characterization of pediatric histiocytoses
American Journal of Hematology · 2023-07 · 98 (7) · 1058-1069
DOI: 10.1002/ajh.26938 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 28.04.2023. Verfasst von Zofia Hélias-Rodzewicz und 42 weiteren Autor:innen. Beteiligte Einrichtung: EA4340 BECCOH, Pathology Department, Ambroise Paré Hospital, AP-HP, Université Paris-Saclay, Boulogne-Billancourt, France. Hauptthemen laut MEDLINE: Histiocytosis, Langerhans-Cell, Erdheim-Chester Disease. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) subtypes. A cohort of 415 children with histiocytosis from the French histiocytosis registry was reviewed and analyzed for BRAF V600E . Most BRAF WT samples were analyzed by next‐generation sequencing (NGS) with a custom panel of genes for histiocytosis and myeloid neoplasia. Of 415 case samples, there were 366 LCH, 1 Erdheim‐Chester disease, 21 Rosai‐Dorfman disease (RDD), 21 juvenile xanthogranuloma (JXG, mostly with severe presentation), and 6 malignant histiocytosis (MH). BRAF V600E was the most common mutation found in LCH (50.3%, n = 184). Among 105 non‐ BRAF V600E ‐mutated LCH case samples, NGS revealed mutations as follows: MAP2K1 ( n = 44), BRAF exon 12 deletions ( n = 26), and duplications ( n = 8), other BRAF V600 codon mutation ( n = 4), and non‐MAP‐kinase pathway genes ( n = 5). Wild‐type sequences were identified in 17.1% of samples. BRAF V600E was the only variant significantly correlated with critical presentations: organ‐risk involvement and neurodegeneration. MAP‐kinase pathway mutations were identified in seven RDD (mostly MAP2K1 ) and three JXG samples, but most samples were wild‐type on NGS. Finally, two MH samples had KRAS mutations, and one had a novel BRAF G469R mutation. Rarely, we identified mutations unrelated to MAP‐kinase pathway genes. In conclusion, we characterized the mutational spectrum of childhood LCH and clinical correlations of variants and subtypes. Variants responsible for JXG and RDD were not elucidated in more than half of the cases, calling for other sequencing approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- EA4340 BECCOH, Pathology Department, Ambroise Paré Hospital, AP-HP, Université Paris-Saclay, Boulogne-Billancourt, France.
- French Reference Center for Histiocytosis, Department of Pediatric Hematology and Oncology, Trousseau Hospital, AP-HP, Sorbonne Université, Paris, France.
- Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Lille, Lille, France.
- Department of Pediatric Immunology, Hematology and Rheumatology, Necker Hospital, AP-HP, Centre-Université Paris Cité, Institut Imagine, Paris, France.
- Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Nantes, Nantes, France.
- Department of Pediatric Immunology and Hematology, Robert Debré Hospital, AP-HP, Nord-Université Paris Cité, Paris, France.
ORCID-Profile: Jean-François Emile, Sébastien Heritier
Zitieren
APA
Hélias-Rodzewicz, Z., Donadieu, J., Terrones, N., Barkaoui, M. A., Lambilliotte, A., Moshous, D., Thomas, C., Azarnoush, S., Pasquet, M., Mansuy, L., Aladjidi, N., Jeziorski, E., Marec-Berard, P., Gilibert-Yvert, M., Spiegel, A., Saultier, P., Pellier, I., Pagnier, A., Pertuisel, S., …, & French Histiocytosis Study Group (2023). Molecular and clinicopathologic characterization of pediatric histiocytoses. American Journal of Hematology, 98(7), 1058-1069. https://doi.org/10.1002/ajh.26938
Vancouver
Hélias-Rodzewicz Z, Donadieu J, Terrones N, Barkaoui MA, Lambilliotte A, Moshous D, et al. Molecular and clinicopathologic characterization of pediatric histiocytoses. American Journal of Hematology. 2023;98(7):1058-1069. doi:10.1002/ajh.26938
BibTeX
@article{HliasRodzewicz2023,
author = {Hélias-Rodzewicz, Zofia and Donadieu, Jean and Terrones, Nathalie and Barkaoui, Mohamed-Aziz and Lambilliotte, Anne and Moshous, Despina and Thomas, Caroline and Azarnoush, Saba and Pasquet, Marlène and Mansuy, Ludovic and Aladjidi, Nathalie and Jeziorski, Eric and Marec-Berard, Perrine and Gilibert-Yvert, Marion and Spiegel, Alexandra and Saultier, Paul and Pellier, Isabelle and Pagnier, Anne and Pertuisel, Sophie and Poiree, Maryline and Bodet, Damien and Millot, Frédéric and Isfan, Florentina and Stephan, Jean-Louis and Leruste, Amaury and Rigaud, Charlotte and Filhon, Bruno and Carausu, Liana and Reguerre, Yves and Kieffer, Isabelle and Brichard, Bénédicte and Ben Jannet, Rim and Bakari, Mariama and Idbaih, Ahmed and Bodemer, Christine and Cohen-Aubart, Fleur and Haroche, Julien and Tazi, Abdellatif and Boudjemaa, Sabah and Fraitag, Sylvie and Emile, Jean-François and Heritier, Sébastien and French Histiocytosis Study Group, French Histiocytosis Study Group},
title = {Molecular and clinicopathologic characterization of pediatric histiocytoses},
journal = {American Journal of Hematology},
year = {2023},
volume = {98},
number = {7},
pages = {1058--1069},
doi = {10.1002/ajh.26938}
}
EUVIMED